Immunome, Inc. (IMNM)

Immunome Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	702	457	27	157	102	-
Market Cap Growth	2317.04%	1605.70%	-82.91%	53.68%	-	-
Enterprise Value	393	320	6	107	63	-2
PE Ratio	-	-4.28	-0.71	-6.35	-5.72	-
PS Ratio	55.32	32.62	-	-	-	-
PB Ratio	2.46	3.81	1.61	3.26	2.47	-
P/FCF Ratio	-32.17	-54.44	-0.93	-8.57	-8.02	-
P/OCF Ratio	-34.33	-60.41	-0.93	-8.60	-8.41	-
EV/Sales Ratio	30.99	22.85	-	-	-	-
EV/EBITDA Ratio	-5.04	-3.02	-0.18	-4.49	-3.68	0.21
EV/EBIT Ratio	-5.02	-3.00	-0.17	-4.35	-3.53	0.20
EV/FCF Ratio	-25.43	-38.14	-0.22	-5.87	-4.94	0.21
Debt / Equity Ratio	0.00	0.01	-	-	0.01	-0.02
Debt / EBITDA Ratio	-0.01	-0.01	-	-	-0.04	-0.06
Debt / FCF Ratio	-0.03	-0.16	-	-	-0.05	-0.06
Quick Ratio	10.07	6.33	2.79	5.07	13.12	1.59
Current Ratio	10.18	6.63	3.09	5.82	14.12	1.88
Asset Turnover	0.08	0.17	0	0	0	0
Interest Coverage	-	-	-	-2470.10	-468.39	-107.79
Return on Equity (ROE)	-220.50%	-286.40%	-139.10%	-49.10%	-624.20%	34.30%
Return on Assets (ROA)	-153.90%	-129.00%	-106.20%	-43.50%	-71.90%	-219.70%
Return on Capital (ROIC)	-82.77%	-90.35%	-221.59%	-52.31%	-29.22%	29.51%
Earnings Yield	-33.07%	-23.36%	-139.97%	-15.76%	-17.48%	-
FCF Yield	-6.53%	-1.84%	-107.96%	-11.67%	-12.47%	-
Buyback Yield / Dilution	-323.10%	-63.64%	-5.10%	-240.41%	-209.85%	83.22%
Total Shareholder Return	-323.10%	-63.64%	-5.10%	-240.41%	-209.85%	83.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).